Joseph Ronald Catapano - 01 Sep 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: Chief Accounting Officer
Issuer ticker: TDOC
Reported as of: 01 Sep 2026
Net transaction value: -$1,726
SEC form: 4
Accepted by SEC: 03 Sep 2026, 16:05:39 UTC
Prior SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Joseph Ronald Catapano filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Sep 2026.

Key facts

This page summarizes Joseph Ronald Catapano's Form 4 filing for Teladoc Health, Inc. (TDOC).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Sep 2026, 16:05.

Change

Previous filing in this sequence was filed on 06 Jul 2026.
Current net transaction value: -$1,726.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001714468 Primary reporting owner

Catapano Joseph Ronald

Relationship: Chief Accounting Officer
Address: C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date: 03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +833
Change %: +6.8%
Price
Shares after: 13,100
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +39
Change %: +0.3%
Price
Shares after: 13,139
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2

TDOC transaction

Common Stock

Sale

Transaction value: $1,726
Shares: -274
Change %: -2.1%
Price: $6.30
Shares after: 12,865
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -833
Change %: -14%
Price: $0.000000^*
Shares after: 5,001
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 833
Exercise price
Footnotes: F1, F4

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
Shares: -39
Change %: -14%
Price: $0.000000^*
Shares after: 232
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39
Exercise price
Footnotes: F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F3

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Footnote F4

On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F5

On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.